Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-α]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine

Journal of Medicinal Chemistry

Volumn 44, Issue 8, 2001, Pages 1151-1157

  Lanig, H ^a   Utz, W ^a   Gmeiner, P ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 (4 CHLOROPHENYL)PIPERAZIN 1 YLMETHYL]PYRAZOLO[1,5 A]PYRIDINE; 3 [[4 (4 CHLOROPHENYL) 1 PIPERAZINYL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; CLOZAPINE; FAUC 113; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON TRANSPORT;

CLOZAPINE; DOPAMINE ANTAGONISTS; MODELS, MOLECULAR; PYRAZOLES; PYRIDINES; PYRROLES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4;

EID: 0035848568     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm001055e     Document Type: Article

References (56)

1. Molecular biology of dopamine receptors
2. Novel dopamine receptors half a decade later
3. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
4. Dopamine D4 receptors: Curiouser and curiouser
5. Dopamine D4 receptors: A new opportunity for research on schizophrenia
6. 4 antagonists
7. 4 Receptors
8. 4-Heterocyclylpiperidines as selective high-affinity ligands at the human dopamine D4 receptor
9. 4 receptor antagonists: Potential antipsychotic agents
10. 4 agonists
11. Discovery of selective dopamine D4 receptor antagonists: 1-Aryloxy-3-(4-aryloxypiperidinyl)-2-propanols
12. 4 ligands: 3-([4-arylpiperazin-1-yl] alkylamino)-2H-1,4-benzoxazines
13. 4 receptor antagonist
14. 4 receptor
15. 4 ligands
16. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists
17. A Series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent
18. 4 receptor ligand
19. SAR of novel biarylmethylamine dopamine D4 receptor ligands
20. 3-[[4-(4-chlorophenyl)piperazin-1-yl]-methyl]-1H-pyrrolo[2,3-b] pyridine: An antagonist with high affinity and selectivity for the human dopamine D4 receptor
21. Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies, and comparison of molecular electrostatic potential maps
22. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: Synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands
23. Conjugated enynes as nonaromatic catechol bioisosteres: Synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D3 subtype
24. Phenyloxazoles and phenylthiazoles as benzamide bioisosteres: Synthesis and dopamine receptor binding profiles
25. The developing practice of comparative molecular field analysis
26. C5-Substituted derivatives of 5-OMe-BPAT: Synthesis and interactions with dopamine D2 and serotonin 5-HT1A receptors
27. Application of comparative molecular field analysis to dopamine D2 partial agonists
28. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors
29. GRID/GOLPE 3D quantitative structure - Activity relationship study on a set of benzamides and naphthamides, with affinity for the dopamine D3 receptor subtype
30. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants
31. 4
32. Neuroleptic piperazinyl-dibenzo-azepines
33. Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems
34. AM1: A new general purpose quantum mechanical model
35. COSMO: A New approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient
36. Improved methods for semiempirical solvation models
37. On the prediction of binding properies of drug molecules by comparitative molecular field analysis
38. Multiple binding modes
39. A detailed study of VESPA electrostatic potential-derived atomic charges
40. How similar is a molecule to another? An electron density measure of similarity between two molecular structures
41. Validation of the general purpose tripos 5.2 force field
42. Iterative partial equalization of orbital electronegativity: A rapid access to atomic charges
43. Multivariate structure-activity relationships between data from a battery of biological tests and an ensemble of structure descriptors: The PLS method
44. 2 guided region selection for CoMFA studies
45. All-orientation search and all-placement search in comparative molecular field analysis
46. Three-dimensional quantitative structure - Activity relationship analyses using comparative molecular field analysis and comparative molecular similarity indices analysis to elucidate selectivity differences of inhibitors binding to trypsin, thrombin, and factor Xa
47. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity